CGB-400 for the Reduction of Facial Redness
NCT04508660
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
25
Enrollment
INDUSTRY
Sponsor class
Conditions
Rosacea
Interventions
DRUG:
CGB-400
Sponsor
CAGE Bio Inc.
Collaborators
[object Object]